Metabolic Targeting of Cancer by a Ubiquinone Uncompetitive Inhibitor of Mitochondrial Complex I
Ontology highlight
ABSTRACT: SMIP004-7 is a small molecule inhibitor of mitochondrial respiration with selective in vivo
anti-cancer activity through a yet unknown molecular target. We demonstrate here that
SMIP004-7 targets drug-resistant cancer cells with stem-like features by inhibiting
mitochondrial respiration complex I (NADH:ubiquinone oxidoreductase, CI). Instead of
affecting the quinone binding site targeted by most CI inhibitors, SMIP004-7 and its
cytochrome P450-dependent activated metabolite(s) have an uncompetitive mechanism
of inhibition involving a distinct N-terminal region of catalytic subunit NDUFS2 that leads
to rapid disassembly of CI. SMIP004-7 and an improved chemical analog selectively
engage NDUFS2 in vivo to inhibit the growth of triple negative breast cancer transplants,
a response mediated at least in part by boosting CD4+ and CD8+ T cell-mediated immune
surveillance. Thus, SMIP004-7 defines an emerging class of ubiquinone uncompetitive CI
inhibitors for cell autonomous and microenvironmental metabolic targeting of
mitochondrial respiration in cancer.
INSTRUMENT(S): Q Exactive
ORGANISM(S): Homo Sapiens (ncbitaxon:9606)
SUBMITTER: Dieter Wolf
PROVIDER: MSV000083740 | MassIVE | Thu May 02 18:50:00 BST 2019
SECONDARY ACCESSION(S): PXD013698
REPOSITORIES: MassIVE
ACCESS DATA